Company profile
VunaNexus AG
VunaNexus uses a patented technology to transform human and livestock urine into two valuable products: a hygienically safe, free of all pollutants, certified and marketable fertiliser called Aurin, and water that can be reused. The main product is a turn-key solution for onsite urine treatment that generates a new type of revenue stream for building owners and has a substantial CO2 impact. We have 6 large scale projects under construction and are financed by the European Space Agency.
Source: startup.ch
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
